The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...
All content for Prescription for Better Access is the property of Mark Hansan and Dr. Scott Howell and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...
An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
Prescription for Better Access
43 minutes
10 months ago
An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
Prescription for Better Access
The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...
